← Leaderboards
Raphael A Clynes
Columbia University Health Sciences
$10,069,778
Attributed
$17,672,299
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$17,672,299 · 14
By mechanism
R01$7,013,272 · 5
DP3$6,608,013 · 1
U01$2,356,247 · 1
P30$829,837 · 2
S10$413,206 · 1
K08$246,474 · 1
Top collaborators
- Robin S Goland6 shared
- Keith L Knutson4 shared
- Edith A Perez4 shared
- Angela M Christiano1 shared
- Lori Sussel1 shared
- Benjamin Tycko1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Judith Korner$12,592,020
- Angela M Christiano$35,497,344
- Steven M Greenberg$3,233,550
Others in their field
Top investigators on “Autoimmunity”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$303,553,812
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Mark S Anderson · University Of California, San Francisco$69,470,335
- Robert S Negrin · Stanford University$48,464,292
Research focus
AutoimmunityT-LymphocyteCellsDiabetes MellitusB-LymphocytesPathway InteractionsT-Cell ActivationInsulin-Dependent Diabetes MellitusPathogenesisAntibodiesBaseFc ReceptorGenerationsMediatingInsulinGeneticAntigen PresentationResearch StudyResponseUptakeCross PresentationDendritic CellsIn VivoDesign
Grant awards (40)
Core G: Flow Cytometry Core$168,497
P30 · FY2016 · DK · contact PI
Core G: Flow Cytometry Core$168,497
P30 · FY2015 · DK · contact PI
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$521,566
R01 · FY2014 · CA
Core G: Flow Cytometry Core$168,497
P30 · FY2014 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$597
U01 · FY2014 · DK
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$511,906
R01 · FY2013 · CA
Enhancing the vaccinal effect of antitumor antibodies$312,080
R01 · FY2013 · CA · contact PI
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$234,808
U01 · FY2013 · DK
Core G: Flow Cytometry Core$152,618
P30 · FY2013 · DK · contact PI
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$549,804
R01 · FY2012 · CA
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$343,193
U01 · FY2012 · DK
Enhancing the vaccinal effect of antitumor antibodies$332,000
R01 · FY2012 · CA · contact PI
Epigenetic events underlying Type I diabetes$6,608,013
DP3 · FY2011 · DK
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$619,306
R01 · FY2011 · CA
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$584,184
U01 · FY2011 · DK
Becton Dickinson LSR II Analytical Flow Cytometer$413,206
S10 · FY2011 · RR · contact PI
Core C: Immunophenotyping$171,728
P30 · FY2011 · AR · contact PI
Pathogenic Role of Islet Cell Autoantibodies in Type I Diabetes$120,000
R56 · FY2011 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$620,883
U01 · FY2010 · DK
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$304,522
R01 · FY2010 · DK · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$100,282
R01 · FY2010 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University$572,582
U01 · FY2009 · DK
Phagocytosis in Pulmonary Alveolar Macrophages$371,575
R01 · FY2009 · HL · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$307,598
R01 · FY2009 · DK · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$21,270
R01 · FY2009 · DK · contact PI
Phagocytosis in Pulmonary Alveolar Macrophages$371,575
R01 · FY2008 · HL · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$328,260
R01 · FY2008 · DK · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$371,682
R01 · FY2007 · DK · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$38,105
R01 · FY2007 · DK · contact PI
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes$322,391
R01 · FY2006 · DK · contact PI
FcR Enhanced Ag Presentation--Induction Tumor Immunity$319,714
R01 · FY2006 · CA · contact PI
FcR Enhanced Ag Presentation--Induction Tumor Immunity$327,409
R01 · FY2005 · CA
FcR Enhanced Ag Presentation--Induction Tumor Immunity$327,409
R01 · FY2004 · CA
FcR Enhanced Ag Presentation--Induction Tumor Immunity$327,409
R01 · FY2003 · CA
FcR Enhanced Ag Presentation--Induction Tumor Immunity$327,409
R01 · FY2002 · CA
Fc receptors in asthma pathogenesis$0
P01 · FY2002 · AI
FC-GAMMA-R IN GLOMERULONEPHRITIS AND AUTOIMMUNITY$123,237
K08 · FY2001 · DK
Fc receptors in asthma pathogenesis$0
P01 · FY2001 · AI
FC-GAMMA-R IN GLOMERULONEPHRITIS AND AUTOIMMUNITY$123,237
K08 · FY2000 · DK
IDENTIFICATION OF FCR EFFECTOR CELLS IN AUTOIMMUNITY$85,250
R03 · FY2000 · AR